Antenatal and histological diagnostics of cystic sacrococcygeal teratoma. Clinical case and literature review
2022

Antenatal and histological diagnostics of cystic sacrococcygeal teratoma

publication Evidence: moderate

Author Information

Author(s): Egle Savukyne, Saule Krzconaviciute, Marija Vaitkeviciute, Egle Machtejeviene, Ieva Rubaviciute

Primary Institution: Lithuanian University of Health Sciences, Kaunas, Lithuania

Hypothesis

How can antenatal diagnostics differentiate between cystic sacrococcygeal teratoma and myelocystocele?

Conclusion

Cystic sacrococcygeal teratoma is diagnosed through ultrasound, MRI, and expert assessment, with histological evaluation confirming the diagnosis.

Supporting Evidence

  • Sacrococcygeal teratoma affects 1 in 35,000–40,000 newborns and is more common in females.
  • Ultrasound can diagnose 25–50% of SCTs during the second trimester.
  • Mortality from SCT complications is three times higher with antenatal diagnosis.

Takeaway

Doctors use special scans to figure out if a baby has a rare tumor before it's born, and they need to check the tissue after birth to be sure.

Methodology

The study involved ultrasound, MRI, and histological examination to diagnose the condition.

Limitations

The study is based on a single case and may not represent broader populations.

Participant Demographics

29-year-old gravida 2, para 2 patient with no significant comorbidities.

Digital Object Identifier (DOI)

10.1515/crpm-2022-0025

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication